Accéder au contenu
Merck

Rapid and Efficient Invasion Assay of Glioblastoma in Human Brain Organoids.

Cell reports (2020-06-11)
Gladiola Goranci-Buzhala, Aruljothi Mariappan, Elke Gabriel, Anand Ramani, Lucia Ricci-Vitiani, Mariachiara Buccarelli, Quintino Giorgio D'Alessandris, Roberto Pallini, Jay Gopalakrishnan
RÉSUMÉ

Glioblastoma (GBM) possesses glioma stem cells (GSCs) that exhibit aggressive invasion behavior in the brain. Current preclinical GBM invasion assays using mouse brain xenografts are time consuming and less efficient. Here, we demonstrate an array of methods that allow rapid and efficient assaying of GSCs invasion in human brain organoids. The assays are versatile to characterize various aspects of GSCs, such as invasion, integration, and interaction with mature neurons of brain organoids. Tissue clearing and quantitative 3D imaging of GSCs in host organoids reveal that invasiveness is inversely correlated with the organoids' age. Importantly, the described invasion assays can distinguish the invasive behaviors of primary and recurrent GSCs. The assays are also amenable to test pharmacological agents. As an example, we show that GI254023X, an inhibitor of ADAM10, could prevent the integration of GSCs into the organoids.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-Neurofilament 200 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-Collapsin Response Mediated Protein 5 Antibody, clone CR-1, culture supernatant, clone CR-1, Chemicon®